Deafblind UK has welcomed a new Chief Executive Officer (CEO). Nikki Morris joined us on 1st January after her predecessor, Steve Conway, retired at the end of 2022.
Nikki said: “I am delighted to join Deafblind UK as CEO at such a pivotal time in its development. With the increasing numbers of people affected by multisensory loss, Deafblind UK’s work is in high demand. Despite the challenges that we all face with the rising cost of living, our commitment to providing services to those in need is as strong as ever.”
Deafblind UK supports people who are affected by both sight and hearing loss across England, Wales and Northern Ireland. We give practical and emotional support to help people to live with their condition and to build their confidence and independence.
Robert Nolan, Chair of Deafblind UK said: “The Board of Trustees and I are delighted to welcome Nikki to Deafblind UK and we are excited about what the future holds for the charity under Nikki’s leadership.”
Nikki continued: “We have a clear vision with exciting plans to deliver and a strong team. I look forward to playing my part in making the UK a more accessible and enjoyable place for all those affected by deafblindness.”
Nikki will oversee the existing services to people who are deafblind, such as emotional support and providing social opportunities. She is also keen to get involved in various new initiatives, including an project to identify and support people with early stages of sight and hearing loss, and the launch of our resources for schools.
Before joining the Deafblind UK team, Nikki was CEO of Age UK Camden where she developed a wide portfolio of outstanding specialist services including day services, care navigation, counselling, and digital inclusion. Nikki was awarded the British Empire Medal in 2022 for services to Camden during the Covid-19 pandemic.
Nikki is a registered nurse and has led the national Cancer Forum at the Royal College of Nursing for many years. She has a long-standing interest in research and education and is a member of the NIHR Public Health Research Prioritization Committee.
